PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer

NCT01152853 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer
HER2

Interventions

DRUG: PF00299804

Sponsor

Seoul National University Hospital

Collaborators

[object Object]